ProtecT Study (Prostate testing for cancer and Treatment)

Prostate cancer is a serious health problem. There are 35,000 new cases every year in the UK, and around 10,000 deaths http://info.cancerresearchuk.org/cancerstats/types/prostate/). The ProtecT study is a research project taking place in nine parts of the UK.

Principal Investigators:

• Professor Jenny Donovan, Head of School, School of Social and Community Medicine, University of Bristol.

• Professor Freddie Hamdy, Head of Nuffield Department of Surgical Sciences, University of Oxford.

• Professor David Neal, Professor of Surgical Oncology, Addenbrooke's Hospital, Cambridge.

Trial Coordinator:

• Dr Athene Lane, Senior Research Fellow, School of Social and Community Medicine, University of Bristol

ProtecT study centres:

Bristol, Southmead Hospital, Lead Urologist, Mr David Gillatt

Newcastle, Freeman Hospital, Lead Urologist, Mr Philip Powell

Sheffield, Royal Hallamshire Hospital, Lead Urologist, Mr Derek Rosario

Birmingham, Queen Elizabeth Hospital, Lead Urologist, Mr Alan Doherty

Cardiff, University Hospital of Wales, Lead Urologist, Professor Howard Kynaston

Edinburgh, Western General Hospital, Lead Urologist, Mr Prasad Bollina

Cambridge, Addenbrookes Hospital, Lead Urologist, Professor David Neal

Leicester, Leicester General Hospital, Lead Urologist, Mr Roger Kockelbergh

Leeds, St James Hospital, Lead Urologist, Mr Alan Paul

 

 

 

 

 

The ProtecT study is funded by the NIHR Health Technology Assessment programme. Ethical approval has been given by Trent Multi-centre Research Ethics Committee.

ISRCTN20141297